FiberNot a GLP-1 receptor agonistNot FDA-approved to treat disease

Glucomannan

Last updated

A highly viscous soluble fiber from konjac root that expands with water in the stomach to promote fullness and slow digestion.

Also known as konjac fiber, Amorphophallus konjac.

What to know

Pooled trials show no significant weight effect; swallowing safety matters.

  • Food Sci Nutr, 2026: meta-analysis of 11 trials (pubmed.ncbi.nlm.nih.gov)
  • Food Funct, 2026: systematic review (pubmed.ncbi.nlm.nih.gov)
  • NIH ODS: weight-loss supplements (ods.od.nih.gov)

Editorial summary reviewed . Literature and label checks below have separate dates.

Prescription GLP-1 medicines: the lowest prices now

  • Lowest compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Lowest compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Lowest FDA-approved, starting dose

    LillyDirect (Eli Lilly)

    from $149/mo

  • Lowest FDA-approved injection, starting dose

    NovoCare (Novo Nordisk)

    $199/fill initially

Findings

What the evidence says

A 2026 meta-analysis of 11 trials found no significant effect on obesity measures, and a 2026 systematic review reports that several human studies found nothing. NIH ODS also reports inconsistent weight-loss results.

  • Food Sci Nutr, 2026: meta-analysis of 11 trials (pubmed.ncbi.nlm.nih.gov)
  • Food Funct, 2026: systematic review (pubmed.ncbi.nlm.nih.gov)
  • NIH ODS: weight-loss supplements (ods.od.nih.gov)

Marketed as: Sold as a natural appetite suppressant for weight loss. A proposed mechanism or a finding about an ingredient does not establish benefit for every finished product.

Safety

What to watch for

Can cause digestive symptoms. Tablets have caused esophageal obstruction; long-term safety is uncertain. Follow the product's fluid instructions.

  • NIH ODS: weight-loss supplements (ods.od.nih.gov)

Literature search counts

Counts · Nov 16, 2026 UTC
RCT-tagged publications
76 (europepmc.org/search) (RCT-tagged publications)
Systematic-review publications
48 (europepmc.org/search) (Systematic-review publications)
All search matches
4,303 (europepmc.org/search) (All search matches)

These are search matches, not a count of independent trials or proof of benefit. Publication types overlap. Results may include animal research, articles mentioning several ingredients, or retracted work. Counts do not assess study quality and may change after retrieval.

Labels

NIH product-label records

A sample of NIH Dietary Supplement Label Database records. Listing is not FDA approval, proof of effectiveness or confirmation a product is still sold.

Label sample · Nov 17, 2026 UTC
  • Glucomannan Konjac RootOff market
    Nature's Way
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan Pure Powder
    NOW
    Powder
    View label (dsld.od.nih.gov)
  • Glucomannan Pure PowderOff market
    NOW
    Powder
    View label (dsld.od.nih.gov)
  • Glucomannan RootOff market
    Nature's Way
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan RootOff market
    Nature's Way
    Capsule
    View label (dsld.od.nih.gov)
  • Konjac Root Glucomannan 2000 mg
    Nova Nutritions
    Powder
    View label (dsld.od.nih.gov)
  • Glucomannan 575 mg
    NOW
    Capsule
    View label (dsld.od.nih.gov)
  • Pure Konjac Root Glucomannan 500 mgOff market
    Good 'N Natural
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan From Konjac RootOff market
    Nature's Way
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan Pure Powder - from Konjac RootOff market
    NOW
    Powder
    View label (dsld.od.nih.gov)
  • Glucomannan Konjac Root 1000 mg
    Sundown Naturals
    Capsule
    View label (dsld.od.nih.gov)
  • GlucomannanOff market
    NOW
    Capsule
    View label (dsld.od.nih.gov)
  • GlucomannanOff market
    NOW
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan +
    Wonder Laboratories
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan +Off market
    DC
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan +
    Wonder Laboratories
    Capsule
    View label (dsld.od.nih.gov)
  • GlucomannanOff market
    NOW
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan +
    DC
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan 575 mgOff market
    NOW
    Capsule
    View label (dsld.od.nih.gov)
  • Glucomannan 100% Pure PowderOff market
    NOW
    Powder
    View label (dsld.od.nih.gov)

Source: NIH Dietary Supplement Label Database (DSLD) (dsld.od.nih.gov/results) · as of Nov 17, 2026

Dietary supplements are not FDA-approved to treat disease; label facts are shown, efficacy claims are not endorsed.
From PubMed

Latest glucomannan trials and reviews

  • Glucomannan and resistant starch in obesity management: a systematic review of satiety, gut fermentation, and weight-related and metabolic outcomes (pubmed.ncbi.nlm.nih.gov/42765172)

    Systematic review · Food Funct · Oct 19, 2026 · Kusuma RA et al.

  • [The Effect of Konjac Glucomannan on Blood Glucose and Insulin Levels in Obese Patients With Prediabetes] (pubmed.ncbi.nlm.nih.gov/42369710)

    Randomized trial · Sichuan Da Xue Xue Bao Yi Xue Ban · May 1, 2026 · Wu R et al.

Listed from Europe PMC as published, newest first. A listing here is not a judgement of a study's quality or a recommendation.

Questions

Glucomannan: common questions

Does Glucomannan work for weight loss?

A 2026 meta-analysis of 11 trials found no significant effect on obesity measures, and a 2026 systematic review reports that several human studies found nothing. NIH ODS also reports inconsistent weight-loss results. It is not a substitute for an FDA-approved GLP-1 medication.

Is Glucomannan a GLP-1 or "natural Ozempic"?

No. Glucomannan is a fiber supplement marketed as "natural GLP-1" support, but it is not a GLP-1 receptor agonist and is not FDA-approved to treat obesity or type 2 diabetes. It does not work the way semaglutide or tirzepatide do. Humanome, an educational atlas we also run, explains how semaglutide acts on the pancreas, stomach and liver.

Is Glucomannan safe?

Can cause digestive symptoms. Tablets have caused esophageal obstruction; long-term safety is uncertain. Follow the product's fluid instructions. Dietary supplements are not reviewed by the FDA for safety and quality the way approved drugs are, so talk with a licensed clinician before starting, especially alongside a prescription medication.

Dietary supplements are not FDA-approved to diagnose, treat, cure, or prevent any disease, including obesity or type 2 diabetes. None of these ingredients is a GLP-1 receptor agonist, and none is a substitute for a prescription GLP-1 medicine. This page is informational only and is not medical advice. Talk with a licensed clinician before starting, stopping, or combining any supplement, especially alongside a prescription medication.
Related

Other fiber supplements